• 
  Nicolas Massart, Christophe Millet, Hélène Beloeil, Pierre Fillatre, Caroline Rouxel, et al.. How green is my reusable bronchoscope?. Anaesthesia Critical Care & Pain Medicine, 2024, pp.101420. ⟨10.1016/j.accpm.2024.101420⟩. ⟨hal-04695675⟩
• 
  Vanessa Gauttier, Sabrina Pengam, Justine Durand, Kevin Biteau, Caroline Mary, et al.. Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance. Journal of Clinical Investigation, 2020, 130 (11), pp.6109-6123. ⟨10.1172/JCI135528⟩. ⟨hal-03001660⟩
• 
  Quentin Duché, Hervé Saint-Jalmes, Oscar Acosta, Parnesh Raniga, Pierrick Bourgeat, et al.. Partial volume model for brain MRI scan using MP2RAGE. Human Brain Mapping, 2017, 38 (10), pp.5115-5127. ⟨10.1002/hbm.23719⟩. ⟨hal-01618006⟩
• 
  Delphine Leclerc, Louise Goujon, Sylvie Jaillard, Bénédicte Nouyou, Laurence Cluzeau, et al.. Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient. The Crispr Journal, 2023, 6 (1), pp.17-31. ⟨10.1089/crispr.2022.0045⟩. ⟨hal-03968195⟩
• 
  J.Y. Blay, N. Penel, T. Valentin, P. Anract, F. Duffaud, et al.. Improved nationwide survival of sarcoma patients with a network of reference centers. Annals of Oncology, 2024, 35 (4), pp.351-363. ⟨10.1016/j.annonc.2024.01.001⟩. ⟨inserm-04658953⟩
• 
  Lucia Carril-Ajuria, Emeline Colomba, Luigi Cerbone, Carmen Romero-Ferreiro, Laurence Crouzet, et al.. Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma. European Journal of Cancer, 2021, 151, pp.106-114. ⟨10.1016/j.ejca.2021.04.009⟩. ⟨hal-04242389⟩
• 
  Anthony Turpin, Thierry de Baere, Alexandra Heurgué, Karine Le Malicot, Isabelle Ollivier-Hourmand, et al.. Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study. Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (2), pp.101464. ⟨10.1016/j.clinre.2020.05.012⟩. ⟨hal-04548045⟩
• 
  Emeric Boisteau, Eric François, Thomas Aparicio, Karine Le Malicot, Rabia Boulahssass, et al.. SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer. Digestive and Liver Disease, 2022, 54 (6), pp.747-754. ⟨10.1016/j.dld.2022.03.001⟩. ⟨hal-03632563⟩
• 
  Sruthi Vijaya Retnakumar, Ramasatyaveni Geesala, Alexis Bretin, Julien Tourneur-Marsille, Eric Ogier-Denis, et al.. Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases. Journal of Autoimmunity, 2022, 128, pp.1-11. ⟨10.1016/j.jaut.2022.102814⟩. ⟨hal-03632352⟩
• 
  Grégoire Le Gac, Alexandre Mansour, Martin Labory, Erwan Flecher, Céline Chabanne, et al.. Patient-reported outcomes: validation of the French Quality of Recovery-15 score in cardiac surgery. British Journal of Anaesthesia, 2024, 133 (2), pp.450-452. ⟨10.1016/j.bja.2024.04.056⟩. ⟨hal-04646806⟩
• 
  Lyria Amari, Pascale Tomasini, Emmanuelle Dantony, Gaëlle Rousseau-Bussac, Charles Ricordel, et al.. Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study). Lung Cancer, 2024, 193, pp.107843. ⟨10.1016/j.lungcan.2024.107843⟩. ⟨hal-04652518⟩
• 
  Ester Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz, Jan Grzelak, Noel P. Fuste, et al.. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche. Journal of Pathology, 2024, 263 (4-5), pp.482-495. ⟨10.1002/path.6299⟩. ⟨hal-04652471⟩
• 
  Cedric Hemon, Blanche Texier, Hilda Chourak, Antoine Simon, Igor Bessieres, et al.. Indirect deformable image registration using synthetic image generated by unsupervised deep learning. Image and Vision Computing, 2024, 148, pp.105143. ⟨10.1016/j.imavis.2024.105143⟩. ⟨hal-04651011⟩
• 
  Cindy Neuzillet, Marie Decraecker, Hélène Larrue, Line Ntanda-Nwandji, Louise Barbier, et al.. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver ( AFEF ). Liver International, 2024, Online ahead of print. ⟨10.1111/liv.15948⟩. ⟨hal-04647913⟩
• 
  Ulrich Jarry, Mégane Bostoën, Jérôme Archambeau, Raphaël Pineau, Laura Chaillot, et al.. Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer. PLoS ONE, 2024, 19 (6), pp.e0304914. ⟨10.1371/journal.pone.0304914⟩. ⟨hal-04650264⟩
• 
  Gael S. Roth, Loic Verlingue, Matthieu Sarabi, Jean Frédéric Blanc, Emmanuel Boleslawski, et al.. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT). European Journal of Cancer, 2024, 202, pp.114000. ⟨10.1016/j.ejca.2024.114000⟩. ⟨hal-04626861⟩
• 
  Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, Richard Finn, Junji Furuse, et al.. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 2023, 401 (10391), pp.1853-1865. ⟨10.1016/S0140-6736(23)00727-4⟩. ⟨hal-04089083⟩
• 
  Louis-Marie Terrier, Luc Bauchet, Valérie Rigau, Aymeric Amelot, Sonia Zouaoui, et al.. Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database. Neuro-Oncology, 2017, 19 (5), pp.678-688. ⟨10.1093/neuonc/now186⟩. ⟨hal-02051153⟩
• 
  Coline Montégut, Jean-Sébastien Guillamo, François Ducray, Caroline Dehais, Cohen-Jonathan Moyal Elisabeth, et al.. Predictive geriatric factors in elderly patients treated for idh-mutant high-grade gliomas: a French Pola network study. Neuro-Oncology, 2021, 23 (6), pp.153. ⟨10.1093/neuonc/noab196.600⟩. ⟨hal-03600574⟩
• 
  Jeremie Naffrichoux, Pierre Poupin, William Pouillot, Claude Linassier, Nathalie Rioux-Leclercq, et al.. PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort. European Journal of Cancer, 2024, 205, pp.114121. ⟨10.1016/j.ejca.2024.114121⟩. ⟨hal-04615732⟩

718

728